Skip to main content
. 2023 Jun 7:1–17. Online ahead of print. doi: 10.1007/s40615-023-01598-2

Table 1.

Scoping review STARLITE principles

Sampling strategy Articles from public policy, health, pharmacy, social sciences, government documents, and provincial formularies
Types of studies Peer-reviewed and non-peer reviewed, policy papers, dissertations, and qualitative studies
Approaches to searching Subject, citation, and hand and internet searches
Range 2010–2021 (Earliest conversations about Pharmacare in Canada)
Limits English language only
Inclusion

Inclusion (Ontario specific):

Regulatory governance (policy, law, and legislation) pertaining to access medicines or COVID-19 vaccines; pharmacogovernance and access to medicines or vaccines; racism and access to medicines or vaccines; equity and access to medicines or vaccines; GIS studies of COVID-19 vaccination sites or pharmacies in Ontario

Exclusion

Drug adverse event studies; COVID-19 vaccine adverse event studies; access to medicines policy outside Canada; theoretical papers on access to medicines or vaccines (not Ontario specific); access to medicines or vaccines in which racism or BIPOC is not referenced; equity and medicines or vaccines in which racism or BIPOC is not referenced

Terms [COVID-19 OR coronavirus OR “SARS-CoV-2” OR “2019-nCoV”] OR [pharmaceutical OR medicine OR medication OR vaccine] AND [“access to medicines” OR “allocation of vaccines” OR procurement OR distribution] AND [government OR governance OR pharmacogovernance OR ministry OR administration OR “federal government” OR “provincial government” OR state] AND [racism OR racist OR race OR marginalized OR racialized] AND [Black OR Indigenous OR Aboriginal OR First Nations OR Métis OR BIPOC OR “people of colour”] AND [Ontario OR Toronto]
Electronic sources Academic One File, Canadian Electronic Library, Canadian Periodicals Index Quarterly, Indigenous Studies Portal, Scholars Portal, Canadian Public Documents Collection, Directory of Open Access Journals, Google Scholar, JSTOR, Project MUSE, PubMed, Theses Canada, CBC Digital Archives, Cochrane Database of Systematic Reviews, Conference Board of Canada e-Library, Index to Canadian Legal Literature, LEGISinfo, Journals@OVID, LabourSource, Omni, Ontario Government Documents Collection, Open Dissertations, PLOS, PAIS Index, Policy File Index, Politics Collection, Semantic Scholar, SSRN

*Pharmacogovernance: accountability and transparency; participation and representation; inclusion and equity; ethics; communication; policy, regulation and law; resource allocation; stakeholder cooperation; responsiveness; effectiveness and efficiency. Additional search from the following grey literature (newspaper, magazines, blogs, tweets, and Ontario budget) sources will be conducted